Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies

Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies

Hepatitis B virus (HBV) chronically infects over 250 million people worldwide and causes nearly 1 million deaths per year due to cirrhosis and liver cancer. Approved treatments for chronic infection include injectable type-I interferons and nucleos(t)ide reverse transcriptase inhibitors. A small min...

Full description

Bibliographic Details
Main Authors: Laura A. Novotny, John Grayson Evans, Lishan Su, Haitao Guo, Eric G. Meissner
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Viruses
Subjects:
hepatitis B virus
interferon lambda
innate immunity
seroclearance
Online Access:https://www.mdpi.com/1999-4915/13/6/1090

Internet

https://www.mdpi.com/1999-4915/13/6/1090

Similar Items